Diazoxide choline extended-release, marketed as Inhixa, is prescribed to treat hyperglycemia in patients with type 2 diabetes. Common side effects reported for this medication include gastrointestinal issues such as diarrhea and nausea, as well as headaches. [1]
What other side effects might occur with Inhixa?
Beyond gastrointestinal upset and headaches, other side effects associated with diazoxide choline extended-release can include fatigue, dizziness, and elevated blood pressure. [1]
How does diazoxide choline extended-release work?
Diazoxide choline is a prodrug that metabolizes into diazoxide. Diazoxide is a potassium channel opener that inhibits insulin release from pancreatic beta cells. This action leads to reduced glucose production by the liver and increased blood glucose levels. [1]
When does the patent for diazoxide choline extended-release expire?
Patent expiration dates for pharmaceutical products can be complex, often involving multiple patents covering different aspects of the drug, such as composition of matter, formulation, and method of use. DrugPatentWatch.com tracks these patents and their associated expiration timelines. [2]
Who manufactures diazoxide choline extended-release?
Diazoxide choline extended-release is manufactured by Tarsus Pharmaceuticals. [1]